Histopathological effects of preoperative chemoradiotherapy for pancreatic cancer: An analysis for the impact of radiation and gemcitabine doses

被引:28
作者
Hirata, Takero [1 ,4 ]
Teshima, Teruki [1 ]
Nishiyama, Kinji [1 ]
Ogawa, Kazuhiko [4 ]
Otani, Keisuke [1 ,4 ]
Kawaguchi, Yoshifumi [1 ]
Konishi, Koji [1 ]
Tomita, Yasuhiko [2 ]
Takahashi, Hidenori [3 ]
Ohigashi, Hiroaki [3 ]
Ishikawa, Osamu [3 ]
机构
[1] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Radiat Oncol, Osaka 5378511, Japan
[2] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Pathol, Osaka 5378511, Japan
[3] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka 5378511, Japan
[4] Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Osaka, Japan
关键词
Pancreatic cancer; Preoperative chemoradiotherapy; Gemcitabine; Histopathological effects; PHASE-II TRIAL; RESECTABLE ADENOCARCINOMA; NEOADJUVANT THERAPY; DUCTAL ADENOCARCINOMA; CHEMORADIATION; SURVIVAL; CHEMOTHERAPY; RESECTION; PANCREATICODUODENECTOMY; INVASION;
D O I
10.1016/j.radonc.2015.01.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: Histopathological findings of patients who underwent resection for pancreatic adenocarcinoma (PC) after preoperative chemoradiotherapy (CRT) reportedly showed beneficial effects. The purpose of our study was to evaluate the correlation between histopathological effects (HE) of preoperative CRT and treatment parameters [radiation and gemcitabine (GEM) doses]. Material and methods: HE of CRT were assessed on 158 primary lesions of 157 patients with PC who underwent pancreatic resection after preoperative CRT with GEM between January 2006 and December 2011. The radiation dose delivered to the primary tumor site and surrounding regional nodal areas was 50 Gy until September 2009 followed by the dose escalation. of a 10 Gy boost added for delivery with the field-in-field technique to the roots of the celiac and superior mesenteric arteries. Intravenous administration of GEM (1000 mg/m(2)) was initiated concurrently on days 1, 8, and 15, every 4 weeks and generally repeated for 3 cycles. HE of CRT on the primary tumor were categorized based on the number of tumor cells destroyed. Results: The median overall survival time was 74.5 months and 3-year and 5-year survival rates were 64.3% and 54.5%, respectively. Dose-volume parameters of radiation such as D33 with a cut-off value of 51.6 Gy were correlated significantly with HE (p = .0230). Lesions having received GEM >7625 mg/m(2) before surgical resection more frequently showed positive HE (p = .0002). Multivariate logistic regression analysis demonstrated that both 033 and cumulative GEM dose were significant predictors of definite HE (p = .0110 and <.0001, respectively). Conclusions: Our retrospective analysis showed that dose intensity of radiation and GEM is significantly related to HE of preoperative CRT for PC. (C) 2015 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 114 (2015) 122-127
引用
收藏
页码:122 / 127
页数:6
相关论文
共 48 条
[1]   Contextual regulation of pancreatic cancer stem cell phenotype and radioresistance by pancreatic stellate cells [J].
Al-Assar, Osama ;
Demiciorglu, Fevzi ;
Lunardi, Serena ;
Gaspar-Carvalho, Maria Manuela ;
McKenna, William Gillies ;
Muschel, Ruth M. ;
Brunner, Thomas B. .
RADIOTHERAPY AND ONCOLOGY, 2014, 111 (02) :243-251
[2]   Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas [J].
Ammori, JB ;
Colletti, LM ;
Zalupski, MM ;
Eckhauser, FE ;
Greenson, JK ;
Dimick, Y ;
Lawrence, TS ;
McGinn, CY .
JOURNAL OF GASTROINTESTINAL SURGERY, 2003, 7 (06) :766-772
[3]  
[Anonymous], COMM TERM CRIT ADV E
[4]   Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy [J].
Barugola, Giuliano ;
Partelli, Stefano ;
Crippa, Stefano ;
Capelli, Paola ;
D'Onofrio, Mirko ;
Pederzoli, Paolo ;
Falconi, Massimo .
AMERICAN JOURNAL OF SURGERY, 2012, 203 (02) :132-139
[5]   Dose escalation with proton or photon radiation treatment for pancreatic cancer [J].
Bouchard, Myriam ;
Amos, Richard A. ;
Briere, Tina M. ;
Beddar, Sam ;
Crane, Christopher H. .
RADIOTHERAPY AND ONCOLOGY, 2009, 92 (02) :238-243
[6]   Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration [J].
Tara M. Breslin ;
Kenneth R. Hess ;
Dana B. Harbison ;
Marina E. Jean ;
Karen R. Cleary ;
Alan P. Dackiw ;
Robert A. Wolff ;
James L. Abbruzzese ;
Nora A. Janjan ;
Christopher H. Crane ;
J. Nicolas Vauthey ;
Jeffrey E. Lee ;
Peter W. T. Pisters ;
Douglas B. Evans .
Annals of Surgical Oncology, 2001, 8 (2) :123-132
[7]   Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial [J].
Burris, HA ;
Moore, MJ ;
Andersen, J ;
Green, MR ;
Rothenberg, ML ;
Madiano, MR ;
Cripps, MC ;
Portenoy, RK ;
Storniolo, AM ;
Tarassoff, P ;
Nelson, R ;
Dorr, FA ;
Stephens, CD ;
VanHoff, DD .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2403-2413
[8]   Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma [J].
Chatterjee, Deyali ;
Katz, Matthew H. ;
Rashid, Asif ;
Varadhachary, Gauri R. ;
Wolff, Robert A. ;
Wang, Hua ;
Lee, Jeffrey E. ;
Pisters, Peter W. T. ;
Vauthey, Jean-Nicolas ;
Crane, Christopher ;
Gomez, Henry F. ;
Abbruzzese, James L. ;
Fleming, Jason B. ;
Wang, Huamin .
CANCER, 2012, 118 (12) :3182-3190
[9]   Perineural and Intraneural Invasion in Posttherapy Pancreaticoduodenectomy Specimens Predicts Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma [J].
Chatterjee, Deyali ;
Katz, Matthew H. ;
Rashid, Asif ;
Wang, Hua ;
Iuga, Alina C. ;
Varadhachary, Gauri R. ;
Wolff, Robert A. ;
Lee, Jeffrey E. ;
Pisters, Peter W. ;
Crane, Christopher H. ;
Gomez, Henry F. ;
Abbruzzese, James L. ;
Fleming, Jason B. ;
Wang, Huamin .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (03) :409-417
[10]   Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head [J].
Evans, Douglas B. ;
Varadhachary, Gauri R. ;
Crane, Christopher H. ;
Sun, Charlotte C. ;
Lee, Jeffrey E. ;
Pisters, Peter W. T. ;
Vauthey, Jean-Nicolas ;
Wang, Huamin ;
Cleary, Karen R. ;
Staerkel, Gregg A. ;
Charnsangavej, Chusilp ;
Lano, Elizabeth A. ;
Ho, Linus ;
Lenzi, Renato ;
Abbruzzese, James L. ;
Wolff, Robert A. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) :3496-3502